Published in Vaccine Weekly, April 2nd, 2003
According to recent research from Germany, "The various research periods leading to the development of paraspecific vaccines are described. Paraspecific vaccines are new, pyrogen-free, non-toxic preparations that contain non-immunizing antigens and can be used to generate endogenic protective, non-antigen specific mechanisms in the sense of paramunization in humans and animals."
"They consist of highly attenuated and inactivated (0.05% Betapropiolactone) virus strains of various poxvirus genera," said A. Mayr at Ludwig-Maximilians-University of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.